Lyell Immunopharma (LYEL) Cash & Current Investments (2020 - 2026)
Lyell Immunopharma (LYEL) recorded Cash & Current Investments of $204.1 million in Q2 2026, down 26.3% from $276.79 million a year earlier and down 19.7% from the prior quarter.
Powered by 
Analysis
Lyell Immunopharma (LYEL) Cash & Current Investments (2020 - 2026) Analysis & Trends
At the end of FY2025, Lyell Immunopharma reported Cash & Current Investments of $247.22 million, down 33.3% from FY2024.
- Annual Cash & Current Investments has declined for three straight years, with a five-year compound annual growth rate of -16.6% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $370.53 million in FY2024 (-32.2%), $546.22 million in FY2023 (-14.7%), $640.15 million in FY2022 (+4.1%) and $614.79 million in FY2021 (+0.4%).
- The Q2 2026 figure is the lowest quarterly Cash & Current Investments since Q3 2020.
- On a year-over-year basis, Cash & Current Investments has declined for 14 consecutive quarters, with an average decline of 30.6% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 358.9% in Q3 2021, against a decline of 43.6% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $254.02 million (Q1 2026), $247.22 million (Q4 2025) and $319.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Lyell Immunopharma | 220.32 Mn | -804.65 Mn | - | 204.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 204.10 Mn |
| Mar 31, 2026 | 254.02 Mn |
| Dec 31, 2025 | 247.22 Mn |
| Sep 30, 2025 | 319.62 Mn |
| Jun 30, 2025 | 276.79 Mn |
| Mar 31, 2025 | 301.18 Mn |
| Dec 31, 2024 | 370.53 Mn |
| Sep 30, 2024 | 440.55 Mn |
| Jun 30, 2024 | 491.12 Mn |
| Mar 31, 2024 | 526.30 Mn |
| Dec 31, 2023 | 546.22 Mn |
| Sep 30, 2023 | 575.43 Mn |
| Jun 30, 2023 | 595.75 Mn |
| Mar 31, 2023 | 612.77 Mn |
| Dec 31, 2022 | 640.15 Mn |
| Sep 30, 2022 | 648.13 Mn |
| Jun 30, 2022 | 655.56 Mn |
| Mar 31, 2022 | 613.91 Mn |
| Dec 31, 2021 | 614.79 Mn |
| Sep 30, 2021 | 618.92 Mn |
API Access
Lyell Immunopharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LYEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "LYEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=LYEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();